首页 | 本学科首页   官方微博 | 高级检索  
检索        

肌球蛋白轻链激酶抑制剂的临床应用前景
引用本文:杨桂芝.肌球蛋白轻链激酶抑制剂的临床应用前景[J].大理医学院学报,1999(4).
作者姓名:杨桂芝
作者单位:大理医学院生物化学教研室!大理671000
摘    要:目的:探索肌球蛋白轻链激酶( MLCK) 抑制剂的作用机制及其与临床某些疾病的关系。方法:综述了国内外近年来对MLCK及其抑制剂的研究情况。结果:MLCK的活性与某些临床疾病的发生密切相关,而广泛存在多种植物中的MLCK抑制剂抑制MLCK的活性,具有抗癌,抗病等多种生理功能。结论:MLCK抑制剂的研究从一个方面揭示了某些药物的作用机理,将对体外筛选此类化合物提供一种有用的研究途径。

关 键 词:肌球蛋白轻链激酶  抑制剂  钙调蛋白

Prospects of Myosin Light Chain Kinase Inhibitors in Clinical Applications
Yang Guizhi.Prospects of Myosin Light Chain Kinase Inhibitors in Clinical Applications[J].Journal of Dali Medical College,1999(4).
Authors:Yang Guizhi
Abstract:Objectives: To sum up the inhibiting mechanism of myosin light chain kinase ( MLCK ) and the relationship between MLCK inhibitors and some diseases. Method : Reviewing lots of related literature in China and abroad. Results: Activities of MLCK is closely related with some diseases. The MLCK inhibitors existing in many species of plants can inhibit the activities of MLCK and then give rise to a series of physiological functions such as antitumor, antimalaria and so forth. Conclusion: The related studies on MLCK inhibitors have revealed the mechanism of some medicines and opened up the way of screening or selecting some compounds similar to MLCK inhibitors.
Keywords:Myosin light chain kinase  Inhibitor  Calmodulin
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号